文献速递产科母胎医学

孕产妇发病率与医学辅助生殖治疗类型

Maternal Morbidity and Medically Assisted Reproduction Treatment Types.
PubMed 文献 · Obstet Gynecol · 2024-12-19

基于美国犹他州2009至2017年469919例分娩的出生证明数据,比较不同受孕方式与医学辅助生殖治疗类型的孕产妇发病率比值比。结果显示,辅助生殖技术和官腔内人工授精等侵入性较强的治疗与孕产妇发病率升高相关,而侵入性较弱的治疗则无此关联;多胎妊娠和产科合并症部分解释了该关联,但辅助生殖技术使用自体卵母细胞者仍保持较高比值比。

要点

  • 医学辅助生殖妊娠占4.8%(22543/469919),其孕产妇发病率风险随治疗侵入性增强而升高。
  • 辅助生殖技术使用自体卵母细胞的孕产妇发病率比值比为1.46(95%CI 1.20-1.78),高于未辅助妊娠。
  • 在仅纳入单胎的模型中,控制产科合并症后,各医学辅助生殖组与未辅助妊娠的孕产妇发病率比值比差异不再有统计学显著性。

核心结论

  • 侵入性较强的医学辅助生殖治疗(辅助生殖技术和官腔内人工授精)与较高的孕产妇发病率比值比相关,而侵入性较弱的治疗则无此关联。
  • 该关联部分由侵入性治疗者中多胎妊娠和产科合并症患病率较高解释,但持续存在的关联提示不孕本身可能对孕产妇发病率有贡献。

研究设计与样本

  • 利用出生证明数据,研究2009年至2017年美国犹他州分娩人群中孕产妇发病率,共469919例分娩,其中22543例妊娠通过医学辅助生殖实现(4.8%)。
  • 孕产妇发病率定义为二分类变量,指存在以下任一情况:输血、非计划手术室操作、入住重症监护室、子痫、非计划子宫切除和子宫破裂。
  • 采用逻辑回归评估医学辅助生殖妊娠(总体及按治疗类型)与未辅助妊娠的孕产妇发病率,在调整社会人口学特征、既往合并症、多胎妊娠和产科合并症前后进行比较。

主要发现

  • 通过医学辅助生殖妊娠者孕产妇发病率风险较高,比值比随医学辅助生殖治疗侵入性增强而升高。
  • 考虑多胎妊娠后关联大幅减弱,进一步控制产科合并症后进一步降低;但辅助生殖技术使用自体卵母细胞的比值比为1.46(95%CI 1.20-1.78),仍高于未辅助妊娠。
  • 在仅纳入单胎的模型中,控制产科合并症后,所有医学辅助生殖组与未辅助妊娠的孕产妇发病率比值比差异不再有统计学显著性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare odds of maternal morbidity by mode of becoming pregnant and type of medically assisted reproduction treatments: fertility-enhancing drugs, intrauterine insemination (IUI), and assisted reproductive technology (ART) with autologous or donor oocytes. METHODS: Birth certificates were used to study maternal morbidity among the birthing population in Utah between 2009 and 2017 (N=469,919 deliveries); 22,543 pregnancies occurred through medically assisted reproduction (4.8%). Maternal morbidity was identified as a binary variable, indicating the presence of any of the following: blood transfusion, unplanned operating room procedure, admission to intensive care unit, eclampsia, unplanned hysterectomy, and ruptured uterus. Using logistic regression, we assessed maternal morbidity among medically assisted reproduction pregnancies (overall and by type of treatment) compared with unassisted pregnancies in the overall sample before and after adjustment for individual sociodemographics (age at birth, family structure, level of education, Hispanic origin, parity), and pre-existing comorbidities (ie, chronic hypertension, heart disease, asthma), multifetal gestation, and obstetric comorbidities (ie, placenta previa, placental abruption, cesarean delivery). RESULTS: Individuals becoming pregnant through medically assisted reproduction had higher risk of maternal morbidity, with odds ratios (ORs) increasing as medically assisted reproduction treatments become more invasive. Associations were largely attenuated when accounting for multifetal gestation and further reduced after controlling for obstetric comorbidities. However, ART with autologous oocytes (OR 1.46, 95% CI, 1.20-1.78) maintained higher coefficients compared with unassisted pregnancies. In models including only singletons, after controlling for obstetric comorbidities, the OR differences in maternal morbidity between all medically assisted reproduction groups and unassisted pregnancies were no longer statistically significant. CONCLUSION: More invasive medically assisted reproduction treatments (ART and IUI) are associated with higher odds of maternal morbidity, whereas less invasive treatments are not. This relationship is partially explained by higher prevalence of multifetal gestation and obstetric comorbidities in people undergoing more invasive treatment, but the persistent association suggests subfertility itself may contribute to maternal morbidity.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pelikh A, Smith KR, Myrskylä M, et al. Maternal Morbidity and Medically Assisted Reproduction Treatment Types. Obstet Gynecol. 2024. PMID: 39700505. doi:10.1097/AOG.0000000000005808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。